Watch the video of the online seminar for Illuminating the role of SMARCA2/4 in childhood alveolar rhabdomyosarcoma by targeted protein degradation with ACB1.
Alessio participates to online seminar
11 November 2022
Related articles
2 min read
Investment raises hopes of new dementia treatments University of Dundee spinout Amphista Therapeutics has received a boost in its efforts to develop new drugs for neurogenerative diseases such as dementia.…
Author: UoD Web Team 0 comment(s)
3 min read
A successful collaboration between the University of Dundee and pharmaceutical company Eisai Co Ltd aiming to create innovative new cancer drugs has been extended for a further three years.A successful…
Author: UoD Web Team 0 comment(s)
1 min read
On 24th November the University of Dundee hosted a highly productive visit by a delegation from UKRI, including their Chief Executive, Professor Dame Ottoline Leyser and the Executive Chair of MRC…
Author: UoD Web Team 0 comment(s)
3 min read
An international collaboration, featuring scientists from the University of Dundee, has made a breakthrough they hope will help futureproof a revolutionary new field of drug discovery by preventing resistance in…
Author: UoD Web Team 0 comment(s)
2 min read
Scientists have designed a novel molecule capable of destroying an as-yet undruggable cancer-causing protein – and are making it available for researchers around the world to use in their own…
Author: UoD Web Team 0 comment(s)
2 min read
A research publication by Tasuku Ishida and Alessio Ciulli has been named one of the 2021 SLAS Readers Choice Award winners. The annual awards from the Society for Laboratory Automation…
Author: UoD Web Team 0 comment(s)
3 min read
Spinout named a ‘Fierce 15’ Biotech Companies of 2022 University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies. University of Dundee…
Author: UoD Web Team 0 comment(s)
3 min read
Researchers from the University of Dundee have discovered a small molecule that helps to eliminate a Parkinson’s disease-causing protein. Parkinson’s disease is a progressive neurodegenerative disorder affecting more than 10 million…
Author: UoD Web Team 0 comment(s)
1 min read
Now published in Chemical Society Reviews: Claudia & Alessio’s review on VHL ligands and their use as VHL inhibitors and in PROTAC degraders. Read the full article open access. Authors:…
Author: UoD Web Team 0 comment(s)
4 min read
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of…
Author: UoD Web Team 0 comment(s)